193 related articles for article (PubMed ID: 34292885)
1. Replenishment of TCA cycle intermediates provides photoreceptor resilience against neurodegeneration during progression of retinitis pigmentosa.
Rowe AA; Patel PD; Gordillo R; Wert KJ
JCI Insight; 2021 Sep; 6(17):. PubMed ID: 34292885
[TBL] [Abstract][Full Text] [Related]
2. Reprogramming metabolism by targeting sirtuin 6 attenuates retinal degeneration.
Zhang L; Du J; Justus S; Hsu CW; Bonet-Ponce L; Wu WH; Tsai YT; Wu WP; Jia Y; Duong JK; Mahajan VB; Lin CS; Wang S; Hurley JB; Tsang SH
J Clin Invest; 2016 Dec; 126(12):4659-4673. PubMed ID: 27841758
[TBL] [Abstract][Full Text] [Related]
3. Large-scale phenotypic drug screen identifies neuroprotectants in zebrafish and mouse models of retinitis pigmentosa.
Zhang L; Chen C; Fu J; Lilley B; Berlinicke C; Hansen B; Ding D; Wang G; Wang T; Shou D; Ye Y; Mulligan T; Emmerich K; Saxena MT; Hall KR; Sharrock AV; Brandon C; Park H; Kam TI; Dawson VL; Dawson TM; Shim JS; Hanes J; Ji H; Liu JO; Qian J; Ackerley DF; Rohrer B; Zack DJ; Mumm JS
Elife; 2021 Jun; 10():. PubMed ID: 34184634
[TBL] [Abstract][Full Text] [Related]
4. Potential of Small Molecule-Mediated Reprogramming of Rod Photoreceptors to Treat Retinitis Pigmentosa.
Nakamura PA; Tang S; Shimchuk AA; Ding S; Reh TA
Invest Ophthalmol Vis Sci; 2016 Nov; 57(14):6407-6415. PubMed ID: 27893103
[TBL] [Abstract][Full Text] [Related]
5. Retinitis pigmentosa: impact of different Pde6a point mutations on the disease phenotype.
Sothilingam V; Garcia Garrido M; Jiao K; Buena-Atienza E; Sahaboglu A; Trifunović D; Balendran S; Koepfli T; Mühlfriedel R; Schön C; Biel M; Heckmann A; Beck SC; Michalakis S; Wissinger B; Seeliger MW; Paquet-Durand F
Hum Mol Genet; 2015 Oct; 24(19):5486-99. PubMed ID: 26188004
[TBL] [Abstract][Full Text] [Related]
6. Late-stage rescue of visually guided behavior in the context of a significantly remodeled retinitis pigmentosa mouse model.
Kajtna J; Tsang SH; Koch SF
Cell Mol Life Sci; 2022 Feb; 79(3):148. PubMed ID: 35195763
[TBL] [Abstract][Full Text] [Related]
7. Different effects of valproic acid on photoreceptor loss in Rd1 and Rd10 retinal degeneration mice.
Mitton KP; Guzman AE; Deshpande M; Byrd D; DeLooff C; Mkoyan K; Zlojutro P; Wallace A; Metcalf B; Laux K; Sotzen J; Tran T
Mol Vis; 2014; 20():1527-44. PubMed ID: 25489226
[TBL] [Abstract][Full Text] [Related]
8. A Pro23His mutation alters prenatal rod photoreceptor morphology in a transgenic swine model of retinitis pigmentosa.
Scott PA; Fernandez de Castro JP; Kaplan HJ; McCall MA
Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2452-9. PubMed ID: 24618321
[TBL] [Abstract][Full Text] [Related]
9. Long-term preservation of cone photoreceptors and visual acuity in rd10 mutant mice exposed to continuous environmental enrichment.
Barone I; Novelli E; Strettoi E
Mol Vis; 2014; 20():1545-56. PubMed ID: 25489227
[TBL] [Abstract][Full Text] [Related]
10. The manner of decay of genetically defective EYS gene transcripts in photoreceptor-directed fibroblasts derived from retinitis pigmentosa patients depends on the type of mutation.
Seko Y; Iwanami M; Miyamoto-Matsui K; Takita S; Aoi N; Umezawa A; Kato S
Stem Cell Res Ther; 2018 Oct; 9(1):279. PubMed ID: 30359287
[TBL] [Abstract][Full Text] [Related]
11. Mid-stage intervention achieves similar efficacy as conventional early-stage treatment using gene therapy in a pre-clinical model of retinitis pigmentosa.
Wert KJ; Sancho-Pelluz J; Tsang SH
Hum Mol Genet; 2014 Jan; 23(2):514-23. PubMed ID: 24101599
[TBL] [Abstract][Full Text] [Related]
12. Retinal degeneration modulates intracellular localization of CDC42 in photoreceptors.
Heynen SR; Tanimoto N; Joly S; Seeliger MW; Samardzija M; Grimm C
Mol Vis; 2011; 17():2934-46. PubMed ID: 22128240
[TBL] [Abstract][Full Text] [Related]
13. Optimal timing for activation of sigma 1 receptor in the Pde6b
Wang J; Xiao H; Barwick S; Liu Y; Smith SB
Exp Eye Res; 2021 Jan; 202():108397. PubMed ID: 33310057
[TBL] [Abstract][Full Text] [Related]
14. Antioxidants slow photoreceptor cell death in mouse models of retinitis pigmentosa.
Komeima K; Rogers BS; Campochiaro PA
J Cell Physiol; 2007 Dec; 213(3):809-15. PubMed ID: 17520694
[TBL] [Abstract][Full Text] [Related]
15. Knockout of Ca
Kilicarslan I; Zanetti L; Novelli E; Schwarzer C; Strettoi E; Koschak A
Sci Rep; 2021 Jul; 11(1):15146. PubMed ID: 34312410
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Epigenetic Modifiers LSD1 and HDAC1 Blocks Rod Photoreceptor Death in Mouse Models of Retinitis Pigmentosa.
Popova EY; Imamura Kawasawa Y; Zhang SS; Barnstable CJ
J Neurosci; 2021 Aug; 41(31):6775-6792. PubMed ID: 34193554
[TBL] [Abstract][Full Text] [Related]
17. Metabolite therapy guided by liquid biopsy proteomics delays retinal neurodegeneration.
Wert KJ; Velez G; Kanchustambham VL; Shankar V; Evans LP; Sengillo JD; Zare RN; Bassuk AG; Tsang SH; Mahajan VB
EBioMedicine; 2020 Feb; 52():102636. PubMed ID: 32028070
[TBL] [Abstract][Full Text] [Related]
18. Ribosomal protein S6 kinase 1 promotes the survival of photoreceptors in retinitis pigmentosa.
Lin B; Xiong G; Yang W
Cell Death Dis; 2018 Nov; 9(12):1141. PubMed ID: 30442943
[TBL] [Abstract][Full Text] [Related]
19. A profile of transcriptomic changes in the rd10 mouse model of retinitis pigmentosa.
Uren PJ; Lee JT; Doroudchi MM; Smith AD; Horsager A
Mol Vis; 2014; 20():1612-28. PubMed ID: 25489233
[TBL] [Abstract][Full Text] [Related]
20. A diffusible factor from normal retinal cells promotes rod photoreceptor survival in an in vitro model of retinitis pigmentosa.
Streichert LC; Birnbach CD; Reh TA
J Neurobiol; 1999 Jun; 39(4):475-90. PubMed ID: 10380070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
